The Fleming Fund Phase I: A Summary - Accessible Version
An accessible version of the Fleming Fund's Phase I Report is available here.
The Phase I Report, titled 'The Fleming Fund Phase I: A Summary', showcases the achievements from the first phase of the programme. It also highlights some of the challenges faced when working in global AMR surveillance, and potential solutions to these problems.
The accessible version of the Phase I Report, available below, is compliant with the Public Sector Bodies (Websites and Mobile Applications) (No. 2) Accessibility Regulations 2018. For more information, please click here.
We welcome you to share the accessible version of our Phase I Report with interested colleagues and networks. Once you have read it, we would be grateful if you could complete our feedback survey to help the Fleming Fund improve future publications.
The full document is available here
View docx (140.96 KB)More Like This
The Fleming Fund's Phase I Report is now available.
The Fleming Fund’s Regional Grants programme has been instrumental in tackling antimicrobial resistance (AMR) and addressing the acute impact in low- and middle-income countries (LMICs) where surveillance systems, laboratory capacity, and skilled workforces have historically been limited.